Atai Life Sciences N V (ATAI)

Aug 03, 2025

How volatile is Atai Life Sciences N.V. stock compared to the marketAchieve consistent profits with expert advice - jammulinksnews.com

Aug 03, 2025

Aug 03, 2025

Atai Life Sciences N.V. Stock Analysis and ForecastFree Stock Market Return Analysis - jammulinksnews.com

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Atai Life Sciences N.V. in the next 12 monthsBoost your returns with professional guidance - jammulinksnews.com

Aug 03, 2025

Aug 03, 2025

How many analysts rate Atai Life Sciences N.V. as a “Buy”Dynamic profit expansion - jammulinksnews.com

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Atai Life Sciences N.V.Maximize your gains with professional insights - jammulinksnews.com

Aug 03, 2025

Aug 03, 2025

What drives Atai Life Sciences N.V. stock priceGet timely advice on market trends - jammulinksnews.com

Aug 03, 2025

Aug 03, 2025

Does Atai Life Sciences N.V. stock perform well during market downturnsTrack top-performing stocks effortlessly - jammulinksnews.com

Aug 03, 2025

Aug 02, 2025

How does Atai Life Sciences N.V. generate profit in a changing economyFree Trend-Following Techniques - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

What is the risk reward ratio of investing in Atai Life Sciences N.V. stockDiscover breakthrough stocks with expert help - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

How does Atai Life Sciences N.V. compare to its industry peersSky-high return potential - jammulinksnews.com

Aug 02, 2025

Jul 31, 2025

H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10 - Insider Monkey

Jul 31, 2025

Jul 31, 2025

AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal - Bloomberg.com

Jul 31, 2025

Jul 31, 2025

H.C. Wainwright raises atai Life Sciences stock price target to $15 on BPL-003 potential - Investing.com Australia

Jul 31, 2025

Jul 30, 2025

This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Jul 30, 2025

Jul 29, 2025

Published on: 2025-07-30 03:07:04 - metal.it

Jul 29, 2025

Jul 29, 2025

What makes Atai Life Sciences N.V. stock price move sharplySwing Setup With Technical Confirmation Explained - metal.it

Jul 29, 2025

Jul 29, 2025

This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Benzinga

Jul 29, 2025

Jul 29, 2025

Oppenheimer initiates coverage on ATAI Life Sciences with Outperform rating, $14 PT. - AInvest

Jul 29, 2025

Jul 29, 2025

Oppenheimer initiates atai Life Sciences stock with Outperform rating By Investing.com - Investing.com Nigeria

Jul 29, 2025

Jul 29, 2025

Oppenheimer initiates atai Life Sciences stock with Outperform rating - Investing.com

Jul 29, 2025

Jul 29, 2025

Published on: 2025-07-29 09:29:36 - metal.it

Jul 29, 2025

Jul 28, 2025

Atai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline Focus (ATAI) - Seeking Alpha

Jul 28, 2025

Jul 28, 2025

ATAI Life Sciences Surges Amidst Market Uncertainty - StocksToTrade

Jul 28, 2025

Jul 28, 2025

Why Is ATAI Life Sciences Stock Trading Lower On Monday? - Benzinga

Jul 28, 2025

Jul 28, 2025

Published on: 2025-07-28 17:17:36 - beatles.ru

Jul 28, 2025

Jul 28, 2025

ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News - Yahoo Finance

Jul 28, 2025

Jul 28, 2025

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - 富途牛牛

Jul 28, 2025

Jul 28, 2025

Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 28, 2025

Jul 28, 2025

Nucor, Waste Management And 3 Stocks To Watch Heading Into Monday - Benzinga

Jul 28, 2025

Jul 28, 2025

What is Atai Life Sciences N.V. company’s growth strategyGet insider insights into market trends - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What are Atai Life Sciences N.V. company’s key revenue driversExceptional stock performance - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Why Atai Life Sciences N.V. stock attracts strong analyst attentionFree Access to Community - metal.it

Jul 27, 2025

Jul 26, 2025

Atai Life Sciences (ATAI) Shares Drop 12% After Schizophrenia Dr - GuruFocus

Jul 26, 2025

Jul 25, 2025

Atai Life Sciences shares fall 14.29% after-hours as schizophrenia drug fails to meet main endpoint. - AInvest

Jul 25, 2025

Jul 25, 2025

Atai Life Sciences down 12% after hours on mid-stage failure of schizophrenia asset - Seeking Alpha

Jul 25, 2025

Jul 25, 2025

Published on: 2025-07-26 00:30:53 - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

ATAI Life Sciences stock falls after Recognify’s CIAS drug misses endpoint - Investing.com UK

Jul 25, 2025

Jul 25, 2025

Clinical Trial Reveals Promising Signals for New Schizophrenia Cognitive Drug Despite Missed Endpoint - Stock Titan

Jul 25, 2025

Jul 25, 2025

Canaccord Increases Atai Life Sciences (ATAI) PT, Keeps Buy Rating - Insider Monkey

Jul 25, 2025

Jul 25, 2025

10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey

Jul 25, 2025

Jul 24, 2025

Is Atai Life Sciences N.V. a good long term investmentBreakout profit opportunities - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy Rating - MSN

Jul 24, 2025

Jul 23, 2025

What analysts say about Atai Life Sciences N.V. stockMassive wealth growth - Autocar Professional

Jul 23, 2025

Jul 22, 2025

atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why - MSN

Jul 22, 2025